510(k) device
Tempus ECG-Low EF
Tempus AI, Inc. · Reduced Ejection Fraction Machine Learning-Based Notification Software (QYE, Class II) · First FDA decision Jul 15, 2025, newest Jul 15, 2025Heart failure
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "ECG-Low EF"
MAUDE reports
0
Brand "ECG-Low EF", since 2015
PubMed studies
0
Mentioning "ECG-Low EF"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Tempus ECG-Low EF
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Tempus ECG-Low EF510(k)
K250119 · Decided Jul 15, 2025 · 180 days after receipt
Device type: Reduced Ejection Fraction Machine Learning-Based Notification Software (QYE) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ECG-Low EF", any status and sponsor, newest update first.
- A Multicenter Pragmatic Implementation Study of ECG-AI-Based Clinical Decision Support Software to Identify Low LVEFPivotal-lookingTerminated
Anumana, Inc.Not on our public-company list
NCT05867407 · 11,610 participants · Start Jun 13, 2024 · Primary completion May 30, 2025
Device: Anumana Low EF AI-ECG Algorithm · For: Ventricular Ejection Fraction
Sites: Phoenix, Arizona; Jacksonville, Florida; Rochester, Minnesota · 5 sites in all
Assiut UniversityAcademic, hospital or other
NCT06593990 · 108 participants (planned) · Start Dec 1, 2024 · Primary completion Dec 1, 2025
Device: echocardography; musculoskeletal ultrasonography and 1 more · For: Rhematoid Arthritis
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ECG-Low EF", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QYE
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ECG-Low EF"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QYE.
- ECG Analysis Software (AiTiALVSD)Medical AI Co., Ltd. · 510(k) 2026
- Bunkerhill ECG-EFBunkerHill Health · 510(k) 2025
- ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)Anumana, Inc. · 510(k) 2025
- Eko Low Ejection Fraction Tool (ELEFT)Eko Health, Inc. · 510(k) 2024
- Low Ejection Fraction AI-ECG AlgorithmAnumana, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.